Cargando…
The frequency and clinical impact of HER2 alterations in lung adenocarcinoma
Human epidermal growth factor receptor 2 (HER2 or ErbB2) can be overexpressed, amplified and/or mutated in malignant tumors, and is a candidate for therapeutic targeting. However, molecular associations and clinical significances of these alterations were controversial in lung cancer. In this study,...
Autores principales: | Kim, Eun Kyung, Kim, Kyung A., Lee, Chang Young, Shim, Hyo Sup |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287480/ https://www.ncbi.nlm.nih.gov/pubmed/28146588 http://dx.doi.org/10.1371/journal.pone.0171280 |
Ejemplares similares
-
Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants
por: Cha, Yoon Jin, et al.
Publicado: (2016) -
Genomic characteristics of invasive mucinous adenocarcinoma of the lung with multiple pulmonary sites of involvement
por: Kim, Moonsik, et al.
Publicado: (2021) -
Genomic alterations of ground-glass nodular lung adenocarcinoma
por: Lee, Hyun, et al.
Publicado: (2018) -
Identification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokers
por: Ahn, Jin Woo, et al.
Publicado: (2014) -
Prognostic effect of matrix metalloproteinase-9 in patients with resected Non small cell lung cancer
por: Lee, Chang Young, et al.
Publicado: (2015)